Physician profile
Dabney James
NPI 1851380562
$1,951.11
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $98.28 · 2021: $337 · 2022: $527 · 2023: $405 · 2024: $52.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $398.50 | 2019-2024 | Rybelsus, Ozempic |
| Amgen INC. | $245.42 | 2019-2023 | Prolia, Evenity |
| Pfizer INC. | $181.21 | 2019-2024 | |
| Abbvie INC. | $165.55 | 2020-2023 | |
| Abbott Laboratories | $138.59 | 2021-2023 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $93.32 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $91.62 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $89.48 | 2019-2023 | Spravato |
| Amarin Pharma, INC. | $43.33 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $41.44 | 2022 | |
| Boston Scientific Corporation | $40.57 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Astellas Pharma US INC | $39.82 | 2023 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.85 | 2023-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.35 | 2020-2021 | |
| Esperion Therapeutics, INC. | $32.27 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $32.11 | 2023 | Inspire |
| Corcept Therapeutics | $29.40 | 2019 | |
| Lilly USA, LLC | $28.47 | 2021-2022 | |
| Dexcom, INC. | $28.22 | 2023 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $23.76 | 2019 | |
| Merck Sharp & Dohme LLC | $22.08 | 2019 | |
| Radius Health, INC. | $18.18 | 2019 | |
| Mylan Specialty L.P. | $18.05 | 2019 | |
| Eisai INC. | $15.72 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.71 | 2022 | |
| Exact Sciences Corporation | $13.54 | 2023 | Cologuard Collection Kit |
| Advanced Respiratory, INC | $12.61 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.48 | 2022 | |
| Portola Pharmaceuticals, LLC | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dabney James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.